Epsin is a ubiquitin-binding endocytic adaptor, which is highly concentrated at clathrin-coated pits and coordinates acquisition of bilayer curvature with coat recruitment and cargo selection. Epsin is encoded by three distinct genes in mammals. Epsin 1 and 2 have broad tissue distribution with high-level expression in the brain. In contrast, epsin 3 was reported to be expressed primarily in immature keratinocytes. Here, we show that epsin 3 is selectively expressed at high levels in the stomach (including the majority of gastric cancers), where it is concentrated in parietal cells. In these cells, epsin 3 is enriched and colocalized with clathrin around apical canaliculi, the sites that control acidification of the stomach lumen via the exo-endocytosis of vesicles containing the H/K ATPase. Deletion of the epsin 3 gene in mice did not result in obvious pathological phenotypes in either the stomach or other organs, possibly because of overlapping functions of the other two epsins. However, levels of EHD1 and EHD2, two membrane tubulating proteins with a role in endocytic recycling, were elevated in epsin 3 knockout stomachs, pointing to a functional interplay of epsin 3 with EHD proteins in the endocytic pathway of parietal cells. We suggest that epsin 3 cooperates with other bilayer binding proteins with curvature sensing/generating properties in the specialized traffic and membrane remodeling processes typical of gastric parietal cells.
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adaptor protein | gastric cancer | Hip1R | EH domain | ezrin C lathrin-mediated endocytosis represents the major pathway that cells use for the selective internalization of plasma membrane proteins and their extracellular ligands. Binding of clathrin to the plasma membrane is mediated by the clathrin adaptors (1, 2) . One such adaptor is epsin, which is expressed by three different isoforms in mammals (3) (4) (5) . Epsin comprises an epsin N-terminal homology (ENTH) domain, which directly interacts with the bilayer and also has membrane-deforming properties, followed by an extended, primarily unfolded tail that contains, in sequence, binding motifs for ubiquitin, the endocytic adaptor AP-2, clathrin, and EH domains (3, (6) (7) (8) (9) (10) . Through these multiple interactions, epsin is thought to coordinate the recruitment of ubiquitinated cargo proteins with the nucleation and growth of endocytic clathrin-coated pits.
Most studies to date have focused on epsin 1 and 2, which are concentrated in the brain, but have broad tissue distribution (3, 10, 11) . Little is known about epsin 3, except that it was reported to be expressed, nearly exclusively, in immature keratinocytes (12) . In a survey of several tissues, we have now detected a strikingly selective expression of epsin 3 in the stomach and, more specifically, in its oxyntic region. Such region is enriched in parietal cells (oxyntic cells): that is, the cells specialized for the acidification of the stomach lumen. A unique feature of these cells is a highly developed membrane-recycling machinery at their apical pole that mediates the shuttling of the H/K ATPase between intracellular tubulovesicular structures and the cell surface. Regulation of the pH in the stomach lumen is critically dependent on the exo-and endocytosis of H/K ATPase-containing vesicles. Given the endocytic function of epsin, these findings raised the possibility that highlevel expression of epsin 3 in the stomach may reflect its selective enrichment at apical endocytic sites in gastric parietal cells. The massive specialization of these cells for endocytic recycling makes them a powerful model system toward the elucidation of recycling mechanisms in mammalian cells. Thus, we have characterized the precise localization of epsin 3 in the stomach and we have explored the potential significance of this localization.
Results and Discussion
Epsin 3 Is Expressed at High Levels in the Stomach. As assayed by Western blotting, the distribution of epsin 3 in adult mouse tissues is highly heterogeneous. By far, the highest expression was detected in the stomach ( Fig. 1 A and B) . The much broader expression of epsin 1 and 2 ( Fig. 1B) (11) confirmed the isoform specificity of the anti-epsin 3 antibodies, which was further validated by the absence of immunoreactivity in the corresponding tissues obtained from an epsin 3 knock-out (KO) mouse ( Fig. 1 A and B ) (see below). Further analysis of the expression of epsin 3 in different regions of the stomach [forestomach/cardiac region, fundus, oxyntic region, and pyloric region (13) ] by Western blotting identified the oxyntic region as the site of highest concentration (Fig. 1C) .
Selective Enrichment of Epsin 3 in Gastric Parietal Cells. The cellular localization of epsin 3 in the mouse stomach was examined by immunofluorescence. Low-power views of frozen sections ( Fig.  2A) showed that epsin 3 was predominantly concentrated in parietal cells of the gastric glands, but no labeling was detected in stomach sections of epsin 3 KO mice (Fig. 2B) . Epsin 3 was expressed at only much lower levels in mucosal cells of the stomach surface, and other gastric cells were epsin 3-negative ( Fig. 2 A and  B) . This localization was confirmed by double immunofluorescence for epsin 3 and for H/K ATPase, a specific marker of gastric parietal cells (Fig. 2 C and D) (14) . luminal surface, which is characterized by deep invaginations (canaliculi), is the site where H/K ATPase pumps protons into the gastric lumen (14) . Regulation of this transport is primarily achieved by the incorporation and removal of the H/K ATPase into and from the membrane of the canaliculi by exo-endocytosis. At rest, H/K ATPase is localized primarily in intracellular tubulovesicles. Upon appropriate stimulation, such as in response to histamine, it translocates to the apical membrane leading to a dramatic enlargement of canaliculi and to increased transport of H + into the gastric lumen. This activated state is reversed by the endocytosis of H/K ATPase-containing apical canalicular membrane to regenerate intracellular tubulovesicles (15) .
Because epsin is an endocytic adaptor, we hypothesized that the high levels of epsin 3 in parietal cells reflected a specialized function in the endocytosis of apical membrane. To investigate whether epsin 3 immunoreactivity localized at endocytic sites of canaliculi, semithin sections of the stomach body were stained by immunofluorescence for epsin 3, the H/K ATPase, and ezrin. Ezrin, a component of the membrane-associated cytoskeleton (16) , is highly concentrated at canaliculi and outlines their profiles. Before fixation by perfusion, mice were either injected with histamine, to induce massive exocytosis of H/K ATPase-containing membranes, or with the histamine H2-receptor antagonist cimetidine, to counteract endogenous histamine stimulation and thus to observe parietal cells in their resting state. As expected, the H/K ATPase was localized in the cytoplasm outside the canalicular profiles, as defined by the ezrin signal, in cimetidine-treated samples, but strongly colocalized with ezrin on the dilated canaliculi in histamine-treated samples (Fig. 3A) . These changes reflect a redistribution of H/K ATPase from the tubulovesicles to the apical surface. Epsin 3 had a strongly punctate localization that was juxtaposed to the ezrin signal in both conditions, but colocalized with the H/K ATPase only in stimulated samples, revealing a localization next to the apical canaliculi (Fig. 3B) . Further double-immunofluorescence experiments showed that all epsin 3 dots colocalized in both cimetidineand histamine-treated samples with a subset of clathrin immunoreactive dots, indicating a localization of epsin 3 at endocytic clathrin-coated pits (Fig. 3C) . However, clathrin immunoreactive dots were not restricted to canaliculi, consistent with the wellestablished additional presence of clathrin in the Golgi complex and on endosomes (1, 17) .
These results were complemented by electron microscopic observation of immunogold-labeled ultrathin frozen sections. H/K ATPase immunoreactivity was primarily localized on the apical microvilli in histamine-treated samples and on internal tubulovesicles in cimetidine-treated samples (Fig. 4) . In adjacent sections of the same samples, the great majority of anti-epsin 3 immunogold was localized on pits (40% of the particles) and nearby vesicles (30% of the particles) with a dense coat at the base of apical microvilli in both histamine-and cimetidine-treated stomachs (Fig. 4 and Fig. S1 ). A similar distribution was observed for anticlathrin immunogold used as a positive control (Fig. 4) . To test this hypothesis, an epsin 3 KO mouse was generated (Fig.  S2) . Epsin 3 KO mice were viable with no obvious developmental, behavioral, or breeding defects. No abnormality was detected by visual inspection of the skin, in spite of the reported expression of epsin 3 in immature keratinocytes (12) . The mice stomachs were normal at histological examination (including electron microscopic analysis) and their lumen had a low pH. Furthermore, as in WT stomachs, H/K ATPase immunoreactivity colocalized with ezrin in histamine-treated stomachs, but outside the ezrin-positive canalicular profiles in cimetidinetreated cells, indicating lack of a major defect in the shuttling of membrane from tubulovesicles to the apical canaliculi (Fig. 5) . Most likely, epsin 1 and 2, which are also expressed in the stomach (Fig. 1B) , have overlapping function with epsin 3. Supporting this possibility, double immunolabeling at the light and electron microscopic levels demonstrated colocalization of epsin 1 and 3 in the stomach (epsin 2-specific antibodies suitable for immunolabeling were not available) ( Fig. 6 A and B) .
Selective Increase of EHD Proteins in Epsin 3 KO Stomachs. Often, suppression of the expression of a protein results in adaptive changes in the levels of other proteins, thus providing useful insight into its function and about its functional partners. Based on this rationale, the levels of several endocytic proteins was analyzed in WT and epsin 3 KO stomachs (and WT and epsin 3 KO brains as controls) (Fig. 7A ). Epsin 1 (but not epsin 2) levels were slightly elevated in the KO stomach, most likely reflecting a compensatory mechanism, but no change in epsin 1 levels was observed in brain, where normal expression of epsin 3 is at the limit of detectability. Clathrin, the clathrin adaptor AP-2, and dynamin were expressed at much lower levels in the stomach than in the brain, but did not undergo any change. No change was observed for the epsin interactor Eps15, or for the α or the β subunit of H/K ATPase, a stomach-specific protein, consistent with the lack of an obvious abnormality in its traffic. Interestingly, expression levels of Hip1R (18), EHD1, and EHD2 (19-21) were higher in the stomach than in the brain. Hip1R, a protein that shares partial domain similarity with epsin (it contains an N-terminal ENTH-like domain) and that links clathrin coats to the actin cytoskeleton, was previously shown to be highly concentrated at apical canaliculi of gastric parietal cells and to be implicated in H/K ATPase endocytosis (18, 22) . Furthermore, recent studies in Dictyostelium have suggested a strong functional partnership between epsin and Hip1R at the interface between clathrin-mediated endocytosis and actin (23) . EHD2 was one of the proteins identified in a proteomic screen for proteins concentrated in tubulovesicles (24). More importantly, expression level of EHD1 and EHD2 were higher in epsin 3 KO stomach than in WT (Fig. 7 A and B) . The increased levels of EHD proteins are of significant interest for several reasons. First, EHD proteins play a role in recycling from the endosome to the plasma membrane (20, 21, 25) , and thus may be implicated in membrane shuttling from tubulovesicles to the plasma membrane of canaliculi. Second, purified EHD proteins can deform lipid bilayers both in vitro (19) and in vivo (26, 27) to generate EHD-coated tubules that are in the same size range as tubulovesicles of gastric parietal cells (27, 28) . Third, they contain an EH domain homologous to the EH domain of the epsin interactor Eps15 (i.e., a domain predicting a potential interaction with the NPF motifs present in the C-terminal region of the epsins) (25, 29, 30 ). The increased levels of the EHD1 and EHD2 immunoreactive bands in the KO stomachs were replicated in mice of two independent litters. GAPDH was used as a loading control. A potential interaction of epsin with EHD1 and EHD2 was directly tested in GST pull-downs from stomach extracts using the EH domains of EHD1 and EHD2 (and of Eps15 as a control) as bait (Fig. 8A) . Both epsin 1 and 3 were specifically affinity-purified by the EH domains of all three proteins. Furthermore, EHD1 and EHD2 partially colocalized with HA-tagged epsin 3, both on punctate structures and tubules, when co-overexpressed in COS-7 cells (Fig. 8B) . These findings suggest a functional relation between the epsins and the EHD proteins.
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Concluding Remarks. Collectively, our results demonstrate a selective high-level expression of epsin 3 in gastric parietal cells and suggest a role of epsin in the specialized membrane recycling system of these cells. More specifically, they point to a role of epsin 3 in clathrin-mediated endocytosis at their apical canaliculi. They further suggest a functional link of epsin to the EHD proteins, whose properties makes them likely players in H/K ATPase recycling via tubular membrane intermediates. The intense exo-endocytic traffic in gastric parietal cells is expected to require cyclic conformational changes of membrane proteins. A special property of epsin, among the clathrin adaptors, is to bind ubiquitin. Thus, it will be of interest to determine whether functions of epsin 3 in gastric parietal cells include a role in a qualitycontrol system aimed at removing misfolded and ubiquitinated proteins, similar to what has been recently proposed in another system (31) .
Finally, beyond its cell biological significance, selective expression of epsin 3 in specialized, highly differentiated cells of the stomach may have implications for the classification and staging of gastric cancers. In preliminary results, we have found that the majority of gastric cancers express epsin 3 at high levels, but that the expression of this protein is on average lower in metastasis derived from the same tumor ( Fig. S3 A and B) . Furthermore, on average, epsin 3 mRNA is expressed at lower levels in advanced gastric cancer than in early gastric cancer (Fig.  S3C) . Thus, analysis of epsin 3 expression in gastric cancer may be of diagnostic value.
Materials and Methods
Epsin 3 Gene Targeting. An epsin 3 conditional KO targeting vector was custom made by Gene Dynamics: all of the nine coding exons (≈8 kb) of the espin 3 gene (EPN3) were bracketed by two loxP sites, and an FRT siteflanked neomycin cassette to allow positive selection of ES cells was inserted after the last coding exon (Fig. S2) . The vector was electroporated in Hybrid C57BL/6J-129S1/Sv mouse embryonic stem cells (Yale Cancer Center Animal Genomics Shared Resource); surviving and correctly recombined clones were identified by Southern blotting and injected into blastocysts of C57BL/6J mice. Resulting chimeric mice were mated to a Cre deleter mouse strain (32) to obtain an epsin 3 KO mouse.
Antibodies. Epsin 3-specific mouse monoclonal and rabbit polyclonal antibodies were raised against the human epsin 3 sequence KQNGTKEP-DALDLGILGEAL and the mouse epsin 3 sequence KQNGMKEPEALDLGV-LGEAL, respectively (12) . Sources of other antibodies are listed in the SI Materials and Methods.
Microscopy. Mice were starved overnight and injected intraperitoneally with cimetidine (120 mg/kg) or histamine (20 mg/kg) 30 min before perfusion fixation with 4% formaldehyde in sodium phosphate buffer, pH 7.2. Immunofluorescence staining of thick (10 μm) and semithin (0.5 μm) frozen stomach sections and immunogold labeling of ultrathin frozen sections for electron microscopic analysis were carried out by standard procedures (SI Materials and Methods). Animal work was approved by the Yale University Yale Animal Care and Use Committee (YACUC). For the analysis of transfected fluorescent proteins, COS-7 cells were transfected using Lipofectamine 2000, fixed in 4% formaldehyde, and observed using a spinning disk confocal microscope, as described (33) . The GFP-EHD1 and GFP-EHD2 plasmids were from our laboratory and a kind gift from H. McMahon (Laboratory of Molecular Biology, Cambridge, United Kingdom), respectively.
Biochemical Analyses. SDS/PAGE and Western blotting were carried out by standard methods. GST pull-downs from stomach lysates were performed essentially as described (34) using GST fusions of the EH domain containing regions of human Eps15 (3), and of mouse EHD1 (aa 439-535) and mouse EHD2 (aa 444-544) as bait.
